CFH and atypical hemolytic-uremic syndrome: Unlike STEC-HUS, aHUS is typically associated with genetic mutations in complement-regulating proteins, including complement factor H (CFH), factor I (CFI), membrane cofactor protein (CD46/MCP), complement component C3, or factor B (CFB), or with acquired autoantibodies against CFH that impair regulatory control [14,15].